当前位置:首页 - 行情中心 - 博拓生物(688767) - 财务分析 - 现金流量表

博拓生物

(688767)

  

流通市值:55.94亿  总市值:55.94亿
流通股本:1.49亿   总股本:1.49亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金89,620,712.2465,654,975.3342,177,119.33242,376,948.27
  收到的税费返还5,816,514.5451,382,689.1819,300,948.667,270,887.41
  收到其他与经营活动有关的现金11,642,012.5956,986,608.1331,319,736.516,562,411.06
  经营活动现金流入小计107,079,239.33574,024,272.61392,797,804.49266,210,246.74
  购买商品、接受劳务支付的现金63,686,666.69233,804,822.92163,682,920.12109,148,301.45
  支付给职工以及为职工支付的现金36,420,120.36123,291,462.6588,408,999.5760,498,555.26
  支付的各项税费11,607,527.8421,075,653.7423,398,251.9920,292,655.5
  支付其他与经营活动有关的现金13,353,456.8989,384,232.8643,234,150.8129,277,532.5
  经营活动现金流出小计125,067,771.78467,556,172.17318,724,322.49219,217,044.71
  经营活动产生的现金流量净额-17,988,532.45106,468,100.4474,073,48246,993,202.03
二、投资活动产生的现金流量:
  收回投资收到的现金908,500,0005,471,665,787.444,336,866,6003,409,866,600
  取得投资收益收到的现金1,203,750.157,001,322.735,753,210.894,443,718.76
  处置固定资产、无形资产和其他长期资产收回的现金净额-2,741,395.442,175,000265,000
  投资活动现金流入小计909,703,750.155,481,408,505.614,344,794,810.893,414,575,318.76
  购建固定资产、无形资产和其他长期资产支付的现金22,534,904129,870,805.9367,005,080.4719,987,707.69
  投资支付的现金936,312,8805,219,834,232.163,763,915,892.52,833,825,000
  投资活动现金流出小计958,847,7845,349,705,038.093,830,920,972.972,853,812,707.69
  投资活动产生的现金流量净额-49,144,033.85131,703,467.52513,873,837.92560,762,611.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,640,000---
  其中:子公司吸收少数股东投资收到的现金2,640,000---
  收到其他与筹资活动有关的现金-3,147,5003,147,5003,147,500
  筹资活动现金流入小计2,640,0003,147,5003,147,5003,147,500
  偿还债务支付的现金--249,872.17211,721.07
  分配股利、利润或偿付利息支付的现金-159,875,000.5159,875,000.5159,875,000.5
  支付其他与筹资活动有关的现金-1,329,402.641,325,772.721,325,772.72
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-161,204,403.14161,450,645.39161,412,494.29
  筹资活动产生的现金流量净额2,640,000-158,056,903.14-158,303,145.39-158,264,994.29
四、汇率变动对现金及现金等价物的影响-17,537,266.19-12,677,811.46-9,947,456.31-2,908,169.22
五、现金及现金等价物净增加额-82,029,832.4967,436,853.36419,696,718.22446,582,649.59
  加:期初现金及现金等价物余额1,171,196,284.521,103,759,431.161,103,759,431.161,103,759,431.16
  期末现金及现金等价物余额1,089,166,452.031,171,196,284.521,523,456,149.381,550,342,080.75
补充资料:
  净利润-47,126,834.92-10,741,062.69
  资产减值准备-5,763,033.17-900,521.34
  固定资产和投资性房地产折旧-23,314,377.73-11,456,391.63
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,314,377.73-11,456,391.63
  无形资产摊销-955,984.56-2,860,886.89
  处置固定资产、无形资产和其他长期资产的损失--247,488.75--278,156.7
  固定资产报废损失-42,136.44-10,993.15
  公允价值变动损失--320,319.1--
  财务费用-12,975,556.21-2,342,569.22
  投资损失--3,969,405.85--3,124,451.6
  递延所得税-1,696,537.09-668,655.75
  其中:递延所得税资产减少-1,696,537.09-668,655.75
  存货的减少--2,042,273.7-1,441,308.85
  经营性应收项目的减少-3,785,137.83-20,640,388.09
  经营性应付项目的增加-8,842,273.47--7,977,288.57
  其他-8,782,558.19-8,584,106.85
  现金的期末余额-1,171,196,284.52-1,550,342,080.75
  减:现金的期初余额-1,103,759,431.16-1,103,759,431.16
  现金及现金等价物的净增加额-67,436,853.36-446,582,649.59
公告日期2026-04-252026-04-252025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑